Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Jun;34(6):788–793. doi: 10.1136/gut.34.6.788

Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.

T Hibi 1, M Ohara 1, M Watanabe 1, T Kanai 1, H Takaishi 1, A Hayashi 1, Y Hosoda 1, H Ogata 1, Y Iwao 1, S Aiso 1, et al.
PMCID: PMC1374263  PMID: 8100205

Abstract

In vitro effects of cytokines and therapeutic drugs on antibody dependent cellular cytotoxicity (ADCC) mediated by anticolon antibody were investigated in serum samples from patients with ulcerative colitis. A 51Cr release assay was used to examine ADCC activity with the colon cancer cell line, colo 205, as the target and peripheral blood mononuclear cells as the effector. High ADCC activity was shown in 13 of 32 (41%) patients with ulcerative colitis. This ADCC activity was inhibited by protein A treatment of the serum samples. Interleukin 2 (IL2) activated effector cells could enhance ADCC activity, but interferon-gamma (IFN-gamma) or tumour necrosis factor-alpha (TNF-alpha) had no effect on the cytotoxic activity of effector cells. Treatment of target cells with IFN-gamma increased the vulnerability of these cells to ADCC with a large increase of intercellular adhesion molecule-1 (ICAM-1) expression on their surface. Monoclonal antibodies to ICAM-1 inhibited this IFN-gamma enhanced ADCC activity. Interestingly, prednisolone (PSL) reduced ADCC activity, but sulphasalazine (SASP) or 5-aminosalicylic acid (5-ASA) did not. These results suggest that IL2 and IFN-gamma could enhance colonic epithelial cell injury mediated by the ADCC mechanism in ulcerative colitis and that ADCC enhanced by cytokines is restored by PSL treatment.

Full text

PDF
788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biddle W. C., Pancook J., Goldrosen M., Han T., Foon K. A., Vaickus L. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors. Cancer Res. 1990 May 15;50(10):2991–2996. [PubMed] [Google Scholar]
  3. Brynskov J., Tvede N., Andersen C. B., Vilien M. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut. 1992 Jan;33(1):55–58. doi: 10.1136/gut.33.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen L., Suzuki Y., Wheelock E. F. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages. J Immunol. 1987 Dec 15;139(12):4096–4101. [PubMed] [Google Scholar]
  5. Das K. M., Kadono Y., Fleischner G. M. Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Relationship to disease activity and response to total colectomy. Am J Med. 1984 Nov;77(5):791–796. doi: 10.1016/0002-9343(84)90514-x. [DOI] [PubMed] [Google Scholar]
  6. Deem R. L., Shanahan F., Targan S. R. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol. 1991 Jan;83(1):79–84. doi: 10.1111/j.1365-2249.1991.tb05592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eisenthal A., Rosenberg S. A. Systemic induction of cells mediating antibody-dependent cellular cytotoxicity following administration of interleukin 2. Cancer Res. 1989 Dec 15;49(24 Pt 1):6953–6959. [PubMed] [Google Scholar]
  8. Ellis T. M., McKenzie R. S., Simms P. E., Helfrich B. A., Fisher R. I. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma. J Immunol. 1989 Dec 15;143(12):4282–4286. [PubMed] [Google Scholar]
  9. Gibson P. R., Jewell D. P. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis. Clin Sci (Lond) 1985 Aug;69(2):177–184. doi: 10.1042/cs0690177. [DOI] [PubMed] [Google Scholar]
  10. Hibi T., Aiso S., Yoshida T., Watanabe M., Asakura H., Tsuru S., Tsuchiya M. Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. Clin Exp Immunol. 1982 Jul;49(1):75–80. [PMC free article] [PubMed] [Google Scholar]
  11. Hibi T., Ohara M., Toda K., Hara A., Ogata H., Iwao Y., Watanabe N., Watanabe M., Hamada Y., Kobayashi K. In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut. 1990 Dec;31(12):1371–1376. doi: 10.1136/gut.31.12.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lieberman B. Y., Fiocchi C., Youngman K. R., Sapatnekar W. K., Proffitt M. R. Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci. 1988 Oct;33(10):1297–1304. doi: 10.1007/BF01536683. [DOI] [PubMed] [Google Scholar]
  13. Ligumsky M., Simon P. L., Karmeli F., Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease. Gut. 1990 Jun;31(6):686–689. doi: 10.1136/gut.31.6.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MacDermott R. P., Kane M. G., Steele L. L., Stenson W. F. Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients. Immunopharmacology. 1986 Apr;11(2):101–109. doi: 10.1016/0162-3109(86)90030-5. [DOI] [PubMed] [Google Scholar]
  15. MacDonald T. T., Hutchings P., Choy M. Y., Murch S., Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 1990 Aug;81(2):301–305. doi: 10.1111/j.1365-2249.1990.tb03334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mahida Y. R., Wu K., Jewell D. P. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut. 1989 Jun;30(6):835–838. doi: 10.1136/gut.30.6.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Makgoba M. W., Sanders M. E., Ginther Luce G. E., Gugel E. A., Dustin M. L., Springer T. A., Shaw S. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol. 1988 Apr;18(4):637–640. doi: 10.1002/eji.1830180423. [DOI] [PubMed] [Google Scholar]
  18. Marcussen H. Fluorescent anti-colonic and E. coli antibodies in ulcerative colitis. Scand J Gastroenterol. 1978;13(3):277–281. doi: 10.3109/00365527809179820. [DOI] [PubMed] [Google Scholar]
  19. Munn D. H., Cheung N. K. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Cancer Res. 1987 Dec 15;47(24 Pt 1):6600–6605. [PubMed] [Google Scholar]
  20. Mutchnick M. G., Lee H. H., Hollander D. I., Haynes G. D., Chua D. C. Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease. Clin Immunol Immunopathol. 1988 Apr;47(1):84–92. doi: 10.1016/0090-1229(88)90147-x. [DOI] [PubMed] [Google Scholar]
  21. Ostensen M. E., Thiele D. L., Lipsky P. E. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells. J Immunol. 1987 Jun 15;138(12):4185–4191. [PubMed] [Google Scholar]
  22. Pace J. L., Russell S. W., LeBlanc P. A., Murasko D. M. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J Immunol. 1985 Feb;134(2):977–981. [PubMed] [Google Scholar]
  23. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  24. Shiloni E., Eisenthal A., Sachs D., Rosenberg S. A. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2. J Immunol. 1987 Mar 15;138(6):1992–1998. [PubMed] [Google Scholar]
  25. Snook J. A., Lowes J. R., Wu K. C., Priddle J. D., Jewell D. P. Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis. Gut. 1991 Feb;32(2):163–166. doi: 10.1136/gut.32.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stobo J. D., Tomasi T. B., Huizenga K. A., Spencer R. J., Shorter R. G. In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells. Gastroenterology. 1976 Feb;70(2):171–176. [PubMed] [Google Scholar]
  27. Symington F. W., Santos E. B. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes. J Immunol. 1991 Apr 1;146(7):2169–2175. [PubMed] [Google Scholar]
  28. Van Seventer G. A., Shimizu Y., Horgan K. J., Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol. 1990 Jun 15;144(12):4579–4586. [PubMed] [Google Scholar]
  29. Watson D. W., Quigley A., Bolt R. J. Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells. Gastroenterology. 1966 Dec;51(6):985–993. [PubMed] [Google Scholar]
  30. Webb D. S., Gerrard T. L. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity. J Immunol. 1990 May 1;144(9):3643–3648. [PubMed] [Google Scholar]
  31. Webb D. S., Shimizu Y., Van Seventer G. A., Shaw S., Gerrard T. L. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science. 1990 Sep 14;249(4974):1295–1297. doi: 10.1126/science.1697984. [DOI] [PubMed] [Google Scholar]
  32. Wright R., Truelove S. C. Auto-immune reactions in ulcerative colitis. Gut. 1966 Feb;7(1):32–40. doi: 10.1136/gut.7.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES